Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7Fatigue 7Sezary Syndrome 3Mycosis Fungoides 3Lymphoma 3Prostatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Leukemia 2Depression 2Breast Neoplasms 2Anxiety Disorders 2Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Sleep Disturbance in Advanced Cancer 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Malignancy 1Parasomnias 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Ultraviolet Therapy 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sleep Disturbance in Advanced Cancer × Ultraviolet Therapy × Clear all
NCT07068971 2025-07-16

SWAN

Our Lady's Hospice and Care Services

Phase NA Enrolling by invitation
30 enrolled

Sleep Disturbance in Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡